Richard Vosser
Stock Analyst at J.P. Morgan
(3.24)
# 2,609
Out of 4,662 analysts
1226
Total ratings
49.6%
Success rate
2%
Average return
Main Sectors:
Stocks Rated by Richard Vosser
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LON: AZN AstraZeneca PLC | Maintained: Buy | 16,000p | 12,050p | +32.78% | 37 | Aug 17, 2026 | |
| SWX: NOVN Novartis AG | Maintained: Buy | CHF 135.00 | CHF 127.12 | +6.20% | 120 | Aug 10, 2026 | |
| LON: 0QW0 argenx SE | Maintained: Buy | €950.00 | €881.20 | +7.81% | 4 | Aug 6, 2026 | |
| ETR: BAYN Bayer Aktiengesellschaft | Maintained: Buy | €50.00 | €49.01 | +2.02% | 146 | Aug 4, 2026 | |
| LON: 0QIU Novo Nordisk A/S | Maintained: Hold | kr 250.00 | kr 292.75 | -14.60% | 156 | Jul 31, 2026 | |
| EPA: SAN Sanofi | Maintained: Hold | €95.00 | €78.56 | +20.93% | 166 | Jul 31, 2026 | |
| ETR: SRT3 Sartorius Aktiengesellschaft | Maintained: Buy | €295.00 | €234.70 | +25.69% | 75 | Jul 24, 2026 | |
| EPA: DIM Sartorius Stedim Biotech S.A. | Maintained: Buy | €260.00 | €182.90 | +42.15% | 29 | Jul 24, 2026 | |
| EPA: IPN Ipsen S.A. | Maintained: Hold | n/a | $165.10 | - | 16 | Jun 29, 2026 | |
| ETR: MRK Merck KGaA | Maintained: Buy | €150.00 | €138.35 | +8.42% | 145 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 325.00 | CHF 367.40 | -11.54% | 191 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $1,916.00 | - | 7 | Dec 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $925 → $1,100 | $1,032.86 | +6.50% | 2 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €230.00 → €300.00 | €218.83 | +37.09% | 19 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 3.50 → CHF 3.00 | CHF 3.48 | -13.79% | 15 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $46.48 | - | 21 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $160.31 | - | 4 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4.5 → $4 | $4.33 | -7.62% | 8 | Sep 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €250.00 → €260.00 | €187.80 | n/a | 17 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | CHF 645.00 → CHF 650.00 | CHF 579.20 | n/a | 15 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €3.00 → €3.50 | €0.98 | n/a | 6 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $55 → $40 | $14.37 | n/a | 7 | Dec 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | €42.81 | €53.05 | n/a | 1 | Jan 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 3,000p | 1,658p | n/a | 7 | Sep 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $176 | $41.05 | n/a | 1 | Mar 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $58.20 | n/a | 3 | Dec 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $145 | $127.28 | n/a | 1 | Jul 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $205 → $200 | $29.36 | n/a | 2 | Mar 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | €185.00 | €25.50 | n/a | 1 | Jan 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | kr 1,150 | kr 2,152 | n/a | 1 | Jan 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $34.11 | n/a | 1 | Jan 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $45.83 | n/a | 1 | Apr 11, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $22 | $8.25 | n/a | 1 | Jan 4, 2017 |
AstraZeneca PLC
Aug 17, 2026
Maintained: Buy
Price Target: 16,000p
Current: 12,050p
Upside: +32.78%
Novartis AG
Aug 10, 2026
Maintained: Buy
Price Target: CHF 135.00
Current: CHF 127.12
Upside: +6.20%
argenx SE
Aug 6, 2026
Maintained: Buy
Price Target: €950.00
Current: €881.20
Upside: +7.81%
Bayer Aktiengesellschaft
Aug 4, 2026
Maintained: Buy
Price Target: €50.00
Current: €49.01
Upside: +2.02%
Novo Nordisk A/S
Jul 31, 2026
Maintained: Hold
Price Target: kr 250.00
Current: kr 292.75
Upside: -14.60%
Sanofi
Jul 31, 2026
Maintained: Hold
Price Target: €95.00
Current: €78.56
Upside: +20.93%
Sartorius Aktiengesellschaft
Jul 24, 2026
Maintained: Buy
Price Target: €295.00
Current: €234.70
Upside: +25.69%
Sartorius Stedim Biotech S.A.
Jul 24, 2026
Maintained: Buy
Price Target: €260.00
Current: €182.90
Upside: +42.15%
Ipsen S.A.
Jun 29, 2026
Maintained: Hold
Price Target: n/a
Current: $165.10
Upside: -
Merck KGaA
Jun 1, 2026
Maintained: Buy
Price Target: €150.00
Current: €138.35
Upside: +8.42%
May 1, 2026
Maintained: Hold
Price Target: CHF 325.00
Current: CHF 367.40
Upside: -11.54%
Dec 23, 2025
Maintained: Sell
Price Target: n/a
Current: $1,916.00
Upside: -
Dec 8, 2025
Maintained: Buy
Price Target: $925 → $1,100
Current: $1,032.86
Upside: +6.50%
Dec 8, 2025
Maintained: Buy
Price Target: €230.00 → €300.00
Current: €218.83
Upside: +37.09%
Dec 8, 2025
Maintained: Hold
Price Target: CHF 3.50 → CHF 3.00
Current: CHF 3.48
Upside: -13.79%
Nov 24, 2025
Maintained: Buy
Price Target: n/a
Current: $46.48
Upside: -
Nov 20, 2025
Maintained: Hold
Price Target: n/a
Current: $160.31
Upside: -
Sep 3, 2025
Maintained: Hold
Price Target: $4.5 → $4
Current: $4.33
Upside: -7.62%
Jul 22, 2025
Maintained: Buy
Price Target: €250.00 → €260.00
Current: €187.80
Upside: n/a
Dec 3, 2024
Maintained: Buy
Price Target: CHF 645.00 → CHF 650.00
Current: CHF 579.20
Upside: n/a
Dec 3, 2024
Maintained: Hold
Price Target: €3.00 → €3.50
Current: €0.98
Upside: n/a
Dec 5, 2023
Maintained: Hold
Price Target: $55 → $40
Current: $14.37
Upside: n/a
Jan 3, 2023
Upgraded: Buy
Price Target: €42.81
Current: €53.05
Upside: n/a
Sep 27, 2021
Maintained: Buy
Price Target: 3,000p
Current: 1,658p
Upside: n/a
Mar 18, 2021
Maintained: Buy
Price Target: $176
Current: $41.05
Upside: n/a
Dec 21, 2020
Maintained: Buy
Price Target: n/a
Current: $58.20
Upside: n/a
Jul 28, 2020
Maintained: Buy
Price Target: $145
Current: $127.28
Upside: n/a
Mar 2, 2020
Maintained: Hold
Price Target: $205 → $200
Current: $29.36
Upside: n/a
Jan 6, 2020
Downgraded: Hold
Price Target: €185.00
Current: €25.50
Upside: n/a
Jan 2, 2019
Downgraded: Hold
Price Target: kr 1,150
Current: kr 2,152
Upside: n/a
Jan 2, 2019
Downgraded: Hold
Price Target: n/a
Current: $34.11
Upside: n/a
Apr 11, 2017
Upgraded: Hold
Price Target: n/a
Current: $45.83
Upside: n/a
Jan 4, 2017
Upgraded: Buy
Price Target: $22
Current: $8.25
Upside: n/a